GlassScriptPhysician profile
Colin A Neumann
NPI 1326339458
$26,460.49
in general payments reported to CMS, 2019-2025
31 companies · $5,048 in 2025
The $5,048 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $4,012 · 2021: $11K · 2022: $3,155 · 2023: $1,730 · 2024: $1,299 · 2025: $5,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,420 · Food and Beverage: $3,377 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,420.00 |
| Food and Beverage | $3,376.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,280.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $11,439.21 | 2019-2025 | Dupixent |
| Genzyme Corporation | $6,332.67 | 2019-2025 | |
| Optinose US, INC. | $4,984.53 | 2019-2025 | |
| Inspire Medical Systems, INC. | $631.92 | 2024-2025 | Inspire |
| Smith+Nephew, INC. | $547.09 | 2019-2025 | Tula, Coblation, Halo |
| Stryker Corporation | $357.97 | 2019-2022 | |
| Medtronic, INC. | $346.28 | 2021-2024 | Propel, Ligasure |
| Acclarent, INC | $333.82 | 2020-2022 | |
| Glaxosmithkline, LLC. | $298.69 | 2020-2025 | Nucala |
| Kaleo, INC. | $161.92 | 2019-2023 | Auvi-Q |
| Integra Lifesciences Corporation | $153.56 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Preceptis Medical, INC. | $144.40 | 2024 | Hummingbird Tympanostomy Tube System |
| Lucid Diagnostics INC. | $91.82 | 2022 | |
| Aerin Medical INC. | $85.44 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $65.26 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $59.67 | 2025 | |
| Resmed Corp | $53.75 | 2020 | |
| Merck Sharp & Dohme LLC | $51.71 | 2019-2023 | |
| Karl Storz Endoscopy-America | $48.34 | 2024-2025 | |
| Hikma Pharmaceuticals USA | $40.91 | 2024-2025 | Ryaltris |
| Arbor Pharmaceuticals, INC. | $38.50 | 2019 | |
| Kerecis Limited | $33.88 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ars Pharmaceuticals Operations, INC. | $28.97 | 2025 | Neffy |
| Cumberland Pharmaceuticals, INC. | $24.74 | 2021 | |
| Paratek Pharmaceuticals, INC. | $22.44 | 2025 | Xhance |
| Medtronic USA, INC. | $21.35 | 2020 | |
| Intersect Ent, INC. | $20.22 | 2019 | |
| Pfizer INC. | $16.05 | 2024 | |
| Alk-Abello, INC | $12.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.68 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Neumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.